How long should Plavix (clopidogrel) be held before total hip replacement surgery in a patient with a history of cardiovascular disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Plavix Discontinuation Before Total Hip Replacement

For elective total hip replacement, discontinue Plavix (clopidogrel) 5 days before surgery. 1, 2, 3

Primary Recommendation

The ACC/AHA guidelines consistently recommend stopping clopidogrel at least 5 days before elective surgery to allow adequate platelet function recovery while minimizing bleeding risk. 1, 2 The FDA label for clopidogrel specifically states: "When possible, interrupt therapy with clopidogrel for five days prior to such surgery." 3

Physiologic Rationale

  • Clopidogrel irreversibly inhibits platelets for their entire 7-10 day lifespan. 3, 4
  • Approximately 10-14% of normal platelet function returns for each day after discontinuation. 2
  • After 5 days, sufficient new platelets have been generated to restore adequate hemostasis for most surgical procedures. 1, 2

Special Considerations for Patients with Coronary Stents

Drug-Eluting Stents (DES)

  • Ideally postpone elective total hip replacement for at least 6 months after DES placement. 2
  • If surgery cannot be delayed, consider continuing aspirin monotherapy and stopping only clopidogrel. 2

Bare Metal Stents (BMS)

  • Wait at least 6 weeks after BMS placement before elective total hip replacement. 2, 5

High Thrombotic Risk Patients

  • Consultation with cardiology is essential before discontinuing clopidogrel in patients with recent acute coronary syndrome or stent placement. 6

Urgent Surgery Considerations

For urgent hip fracture surgery, the evidence supports operating within 24-48 hours despite clopidogrel use rather than delaying surgery. 1, 7, 8

  • ACC/AHA guidelines state that for urgent surgery, clopidogrel should be discontinued for at least 24 hours to reduce major bleeding. 1
  • Multiple studies demonstrate that early surgery (<48 hours) in hip fracture patients on clopidogrel does not increase mortality or perioperative bleeding compared to controls. 7, 8
  • Surgical delay beyond 4 days in hip fracture patients increases postoperative mortality, making early intervention critical. 4

Perioperative Management Algorithm

For Elective Total Hip Replacement:

  1. Stop clopidogrel 5 days before surgery 1, 2, 3
  2. Continue aspirin if patient is on dual antiplatelet therapy (unless contraindicated by surgeon preference) 1
  3. Resume clopidogrel within 24 hours after surgery once hemostasis is achieved 2, 3

For Urgent Hip Fracture Surgery:

  1. Stop clopidogrel immediately upon admission 1
  2. Proceed to surgery within 24-48 hours 1, 7, 8
  3. Consider platelet transfusion if significant bleeding occurs (though transfusions within 2-4 hours of last dose may be less effective) 3, 9
  4. Resume clopidogrel within 24 hours postoperatively 2

Common Pitfalls to Avoid

  • Do not delay urgent hip fracture surgery for 5-7 days waiting for clopidogrel washout—this increases mortality without reducing bleeding risk. 7, 8
  • Do not assume all antiplatelet agents have the same washout period—prasugrel requires 7 days, ticagrelor requires 3-5 days. 1, 2
  • Do not restart clopidogrel at maintenance dose (75 mg) if rapid antiplatelet effect is needed—use loading dose of 300-600 mg to achieve effect within 12-15 hours. 2
  • Do not perform elective surgery on patients within 6 months of DES placement without cardiology consultation. 2

Bleeding Risk Mitigation

  • Accept that some increased bleeding may occur with early surgery in urgent cases, but this risk is outweighed by mortality reduction from timely intervention. 7, 8
  • Ensure adequate blood products are available, though transfusion rates are similar between clopidogrel and non-clopidogrel patients in most studies. 8
  • Platelet transfusions may provide some benefit if given more than 2-4 hours after the last clopidogrel dose. 3, 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Perioperative Management of Clopidogrel

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Discontinuation of Effient (Prasugrel) Before Spinal Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Perioperative Management of Clopidogrel for Orbital Floor Reconstruction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.